Compare SEM & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEM | AXGN |
|---|---|---|
| Founded | 1996 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Hospital/Nursing Management | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.7B |
| IPO Year | 2008 | 2013 |
| Metric | SEM | AXGN |
|---|---|---|
| Price | $16.30 | $33.59 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $15.17 | ★ $38.00 |
| AVG Volume (30 Days) | ★ 3.2M | 742.6K |
| Earning Date | 04-30-2026 | 05-07-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.16 | N/A |
| Revenue | N/A | ★ $225,208,000.00 |
| Revenue This Year | $5.45 | $20.31 |
| Revenue Next Year | $4.78 | $16.36 |
| P/E Ratio | $14.04 | ★ N/A |
| Revenue Growth | N/A | ★ 20.21 |
| 52 Week Low | $11.65 | $9.22 |
| 52 Week High | $18.61 | $36.00 |
| Indicator | SEM | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 65.29 | 56.37 |
| Support Level | $16.20 | $30.34 |
| Resistance Level | $16.59 | $34.25 |
| Average True Range (ATR) | 0.03 | 1.41 |
| MACD | -0.02 | 0.22 |
| Stochastic Oscillator | 70.00 | 79.15 |
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically and economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap, and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, and several other countries.